Biotechnology Portfolio Biotechnology Fund Number Of Shares Shorted
| FBIOX Fund | USD 20.89 0.03 0.14% |
Biotechnology Portfolio Biotechnology fundamentals help investors to digest information that contributes to Biotechnology Portfolio's financial success or failures. It also enables traders to predict the movement of Biotechnology Mutual Fund. The fundamental analysis module provides a way to measure Biotechnology Portfolio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotechnology Portfolio mutual fund.
Biotechnology |
Biotechnology Portfolio Biotechnology Mutual Fund Number Of Shares Shorted Analysis
Biotechnology Portfolio's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Biotechnology Portfolio Biotechnology has 0.0 of outstending shares currently sold short by investors. This indicator is about the same for the Fidelity Investments average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Fund Asset Allocation for Biotechnology Portfolio
The fund consists of 96.05% investments in stocks, with the rest of investments allocated between different money market instruments and various exotic instruments.Asset allocation divides Biotechnology Portfolio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Biotechnology Fundamentals
| Price To Earning | 29.21 X | |||
| Price To Book | 3.43 X | |||
| Price To Sales | 7.71 X | |||
| Annual Yield | 0.01 % | |||
| Year To Date Return | 17.57 % | |||
| One Year Return | 40.46 % | |||
| Three Year Return | 2.47 % | |||
| Five Year Return | 6.46 % | |||
| Ten Year Return | 19.82 % | |||
| Net Asset | 4.78 B | |||
| Last Dividend Paid | 0.03 | |||
| Cash Position Weight | 0.41 % | |||
| Equity Positions Weight | 96.05 % |
About Biotechnology Portfolio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotechnology Portfolio Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |